Literature DB >> 7063865

Endogenous opiates and energy balance.

A Mandenoff, F Fumeron, M Apfelbaum, D L Margules.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7063865     DOI： 10.1126/science.7063865

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  Differential involvement of endogenous opioids in sucrose consumption and food reinforcement.

Authors:  Michael D Hayward; Alexandra Schaich-Borg; John E Pintar; Malcolm J Low
Journal:  Pharmacol Biochem Behav       Date:  2006-12-12       Impact factor: 3.533

2.  Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.

Authors:  Aamir R Zuberi; Leigh Townsend; Laurel Patterson; Huiyuan Zheng; Hans-Rudi Berthoud
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

3.  Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability.

Authors:  M R Yeomans; P Wright; H A Macleod; J A Critchley
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  The role of naltrexone in the management of drug abuse.

Authors:  H M Ginzburg; M G MacDonald
Journal:  Med Toxicol       Date:  1987 Mar-Apr

Review 5.  Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment.

Authors:  T Vogt; D Belluscio
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

6.  Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men.

Authors:  V Coiro; L Capretti; G Speroni; A Castelli; L Bianconi; U Cavazzini; A Marcato; R Volpi; P Chiodera
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

7.  Sweet/Fat Preference Taste in Subjects Who are Lean, Obese and Very Obese.

Authors:  Jennifer Leohr; Maria C Kjellsson
Journal:  Pharm Res       Date:  2020-11-19       Impact factor: 4.200
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.